We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.28%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$42.5B
AUM Growth
+$2.36B
(+5.9%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-0.3%
Top 10 Holdings %
Top 10 Hldgs %
33.33%
Holding
1,050
New
87
Increased
310
Reduced
398
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$78.2M |
| 2 |
Amazon
AMZN
|
+$74.6M |
| 3 |
Cisco
CSCO
|
+$69.3M |
| 4 |
Monster Beverage
MNST
|
+$68.9M |
| 5 |
Oracle
ORCL
|
+$67.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$449M |
| 2 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$175M |
| 3 |
AutoZone
AZO
|
+$87M |
| 4 |
Varex Imaging
VREX
|
+$49M |
| 5 |
CVS Health
CVS
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.75% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Healthcare | 12.92% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Mercado Libre
MELI
$97.4B
| $3.15M | 0.01% |
12,553
+325
| +3% | +$83.5K |
|
502
Baidu
BIDU
$37.7B
| $3.06M | 0.01% |
17,091
+439
| +3% | +$79.5K |
|
|
KE
503
Kimball Electronics
KE
$648M
| $2.91M | 0.01% |
161,295
-1,930
| -1% | -$33.3K |
|
|
WBT
504
DELISTED
Welbilt, Inc.
WBT
| $2.88M | 0.01% |
+153,038
| New | +$2.99M |
|
505
Kinder Morgan
KMI
$69.3B
| $2.63M | 0.01% |
137,446
| – | – |
|
506
BlackRock Floating Rate Income Strategies Fund
FRA
$385M
| $2.62M | 0.01% |
186,170
+2,344
| +1% | +$33.5K |
|
|
AMRI
507
DELISTED
Albany Molecular Research Inc
AMRI
| $2.62M | 0.01% |
120,746
-519,285
| -81% | -$9.42M |
|
|
EFR
508
Eaton Vance Senior Floating-Rate Fund
EFR
$314M
| $2.52M | 0.01% |
168,810
-100,000
| -37% | -$1.49M |
|
509
ExxonMobil
XOM
$630B
| $2.51M | 0.01% |
31,118
+19,143
| +160% | +$1.57M |
|
510
Canadian Natural Resources
CNQ
$94.8B
| $2.13M | 0.01% |
150,675
+98,063
| +186% | +$1.48M |
|
511
Exelon
EXC
$46.9B
| $1.91M | ﹤0.01% |
74,288
-230,840
| -76% | -$5.87M |
|
|
BSL
512
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$170M
| $1.87M | ﹤0.01% |
104,283
-47,999
| -32% | -$867K |
|
513
Ovintiv
OVV
$16.3B
| $1.81M | ﹤0.01% |
41,068
+27,289
| +198% | +$1.41M |
|
514
AbbVie
ABBV
$434B
| $1.65M | ﹤0.01% |
22,683
-153
| -0.7% | -$10.3K |
|
515
EQT Corp
EQT
$32.2B
| $1.49M | ﹤0.01% |
46,652
+12,328
| +36% | +$390K |
|
516
Golar LNG
GLNG
$5.12B
| $1.39M | ﹤0.01% |
62,586
+43,680
| +231% | +$1.1M |
|
517
Aptiv
APTV
$9.98B
| $1.34M | ﹤0.01% |
15,257
+10,050
| +193% | +$839K |
|
518
Crown Holdings
CCK
$13.3B
| $1.33M | ﹤0.01% |
22,314
| – | – |
|
519
GSK
GSK
$103B
| $1.29M | ﹤0.01% |
24,002
| – | – |
|
|
AGN.PRA
520
DELISTED
Allergan plc
AGN.PRA
| $1.26M | ﹤0.01% |
5,173
-208,432
| -98% | -$175M |
|
|
PPL
521
PPL Corp
PPL
$26.2B
| $1.26M | ﹤0.01% |
32,481
-2,000
| -6% | -$77.3K |
|
522
Valero Energy
VLO
$86.9B
| $1.15M | ﹤0.01% |
17,062
+6,041
| +55% | +$392K |
|
523
DuPont de Nemours
DD
$19.8B
| $1.12M | ﹤0.01% |
7,010
-790
| -10% | -$126K |
|
|
XIFR
524
XPLR Infrastructure LP
XIFR
$1.09B
| $1.11M | ﹤0.01% |
29,903
+4,334
| +17% | +$149K |
|
|
RDS.B
525
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.09M | ﹤0.01% |
19,988
| – | – |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2017 Portfolio in Review
As of Q2 2017, Loomis, Sayles & Company held 1,050 positions worth $42.5B, up 5.9% from $40.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Loomis, Sayles & Company's Q2 2017 filing shows 87 new, 310 increased, 398 reduced and 100 closed positions. Its largest new stake was Danaher: 762,466 shares worth $57M. The largest sale was Intel, an estimated $449M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Loomis, Sayles & Company's largest Q2 2017 buy was Danaher: 762,466 shares worth $57M.
- Loomis, Sayles & Company added most to Visa in Q2 2017, an estimated $78.2M increase.
- Loomis, Sayles & Company's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $175M.
- Loomis, Sayles & Company fully exited Intel in Q2 2017, selling an estimated $449M.
- Loomis, Sayles & Company's ten largest holdings make up 33% of its $42.5B portfolio in Q2 2017.
- Loomis, Sayles & Company opened 87 new positions and closed 100 in Q2 2017.
- Loomis, Sayles & Company's portfolio value rose 5.9% quarter-over-quarter to $42.5B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2017, filed 14 Aug 2017.